Jason Valent

2.5k total citations
103 papers, 945 citations indexed

About

Jason Valent is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Jason Valent has authored 103 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 61 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Jason Valent's work include Multiple Myeloma Research and Treatments (58 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (37 papers) and Protein Degradation and Inhibitors (19 papers). Jason Valent is often cited by papers focused on Multiple Myeloma Research and Treatments (58 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (37 papers) and Protein Degradation and Inhibitors (19 papers). Jason Valent collaborates with scholars based in United States, Canada and Belgium. Jason Valent's co-authors include Christy Samaras, Mazen Hanna, Faiz Anwer, Brett W. Sperry, Beth Faiman, Jack Khouri, Asad Ikram, Jeffrey A. Zonder, Michael N. Vranian and Rajshekhar Chakraborty and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Jason Valent

94 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Valent United States 18 660 510 408 220 115 103 945
Cindy Varga United States 17 519 0.8× 371 0.7× 266 0.7× 170 0.8× 89 0.8× 60 746
Divaya Bhutani United States 17 454 0.7× 309 0.6× 280 0.7× 142 0.6× 84 0.7× 75 815
Mauricio Ocqueteau Chile 13 352 0.5× 617 1.2× 214 0.5× 179 0.8× 23 0.2× 33 933
Uta Oelschlaegel Germany 18 425 0.6× 770 1.5× 302 0.7× 203 0.9× 49 0.4× 41 1.2k
Zdeněk Adam Czechia 14 482 0.7× 522 1.0× 298 0.7× 100 0.5× 20 0.2× 156 929
Mario Annunziata Italy 17 202 0.3× 592 1.2× 141 0.3× 255 1.2× 33 0.3× 51 776
Anne Marie Stoppa France 18 555 0.8× 844 1.7× 322 0.8× 196 0.9× 47 0.4× 43 1.2k
Anand P. Jillella United States 15 314 0.5× 485 1.0× 280 0.7× 222 1.0× 13 0.1× 55 866
Paola Masolini Italy 17 252 0.4× 389 0.8× 294 0.7× 187 0.8× 29 0.3× 24 849
Pascal Lenain France 14 683 1.0× 859 1.7× 662 1.6× 336 1.5× 26 0.2× 40 1.3k

Countries citing papers authored by Jason Valent

Since Specialization
Citations

This map shows the geographic impact of Jason Valent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Valent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Valent more than expected).

Fields of papers citing papers by Jason Valent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Valent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Valent. The network helps show where Jason Valent may publish in the future.

Co-authorship network of co-authors of Jason Valent

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Valent. A scholar is included among the top collaborators of Jason Valent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Valent. Jason Valent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubio, Andres Carmona, et al.. (2026). Estimated Stressed Blood Volume in Patients With Cardiac Amyloidosis. The American Journal of Cardiology. 266. 59–66.
2.
Dima, Danai, Fauzia Ullah, Beth Faiman, et al.. (2025). Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center. Hematological Oncology. 43(3). e70082–e70082.
3.
Samaras, Christy, Akriti Jain, Jason Valent, et al.. (2025). Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?. Blood. 146(Supplement 1). 2248–2248.
4.
Davis, James A., Danai Dima, Nausheen Ahmed, et al.. (2024). Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma. Transplantation and Cellular Therapy. 30(2). S195–S196. 1 indexed citations
5.
Raza, Shahzad, Christy Samaras, Beth Faiman, et al.. (2024). Impact of T-Cell Redirecting Therapies on Survival Outcomes in Ultra-High-Risk Multiple Myeloma and Plasma Cell Leukemia. Blood. 144(Supplement 1). 7092–7092. 1 indexed citations
6.
Gasoyan, Hamlet, Faiz Anwer, Jason Valent, et al.. (2024). Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities. JCO Oncology Practice. 20(5). 699–707. 2 indexed citations
7.
Jaberi‐Douraki, Majid, Xuan Xu, Danai Dima, et al.. (2024). Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study. Blood Cancer Journal. 14(1). 223–223. 1 indexed citations
8.
Davis, James A., Danai Dima, Nausheen Ahmed, et al.. (2023). Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma. Transplantation and Cellular Therapy. 30(3). 298–305. 18 indexed citations
9.
Dima, Danai, Ang Li, Saeid Mirzai, et al.. (2023). External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs. British Journal of Haematology. 201(2). 280–284. 7 indexed citations
10.
Davis, James A., Danai Dima, Nausheen Ahmed, et al.. (2023). Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma. Blood. 142(Supplement 1). 3503–3503. 2 indexed citations
11.
Martens, Pieter, et al.. (2023). Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis. Circulation Heart Failure. 16(3). e010078–e010078. 15 indexed citations
12.
Xu, Xuan, Shahzad Raza, Jim E. Riviere, et al.. (2023). Identification of genes encoding targets associated with adverse events in multiple myeloma.. Journal of Clinical Oncology. 41(16_suppl). 1556–1556. 2 indexed citations
13.
Dima, Danai, James A. Davis, Nausheen Ahmed, et al.. (2023). Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience. Transplantation and Cellular Therapy. 30(3). 308.e1–308.e13. 40 indexed citations
14.
Covut, Fahrettin, Sanchit Chawla, Christy Samaras, et al.. (2021). Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study. British Journal of Haematology. 193(6). 1213–1219. 25 indexed citations
15.
Li, Yun, Subha Ghosh, Jason Valent, et al.. (2021). A Unique Case of Combined Nodular and Tracheobronchial Amyloidosis. Oxford Medical Case Reports. 2021(2). omaa134–omaa134. 1 indexed citations
16.
Lentzsch, Suzanne, Samuel Pan, Divaya Bhutani, et al.. (2021). Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer Journal. 11(1). 10–10. 70 indexed citations
17.
Ikram, Asad, Joseph P. Donnelly, Brett W. Sperry, et al.. (2018). Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center’s experience. Amyloid. 25(3). 197–202. 50 indexed citations
18.
Blandford, Alexander D., Saloni Kapoor, Gabrielle Yeaney, et al.. (2018). Ocular Adnexal Amyloidosis: A Mass Spectrometric Analysis. American Journal of Ophthalmology. 193. 28–32. 12 indexed citations
19.
Chari, Ajai, Saulius Girnius, Saurabh Chhabra, et al.. (2017). Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 130. 3111–3111. 2 indexed citations
20.
Vranian, Michael N., Brett W. Sperry, Jason Valent, & Mazen Hanna. (2015). Emerging Advances in the Management of Cardiac Amyloidosis. Current Cardiology Reports. 17(11). 100–100. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cindy Varga Breakdown of academic impact, for papers by Divaya Bhutani Breakdown of academic impact, for papers by Mauricio Ocqueteau Breakdown of academic impact, for papers by Uta Oelschlaegel Breakdown of academic impact, for papers by Zdeněk Adam Breakdown of academic impact, for papers by Mario Annunziata Breakdown of academic impact, for papers by Anne Marie Stoppa Breakdown of academic impact, for papers by Anand P. Jillella Breakdown of academic impact, for papers by Paola Masolini Breakdown of academic impact, for papers by Pascal Lenain
Rankless by CCL
2026